120/73 mmHg-80/43 mmHg was observed. The rapidity of the event leads us to assume VAE to be the most probable cause of the event. Immediately, the patient's lung was ventilated with 100% oxygen. The surgery was briefly interrupted and the operative field was covered with normal saline. In view of hypotension 500 ml of hydroxyl ethyl starch and 10 mg of mephenteramine (in 5 mg increments) were administered; simultaneously, approximately 40 ml of air was aspirated through the central venous catheter. Within a period of 15 minutes, the patient's haemodynamic parameters and EtCO 2 returned back to normal. Rest of the surgery was uneventful.
The prerequisites for the entry of gas into the venous system are incision of non-collapsible veins such as diploic veins, emissary veins or dural venous sinuses in presence of sub-atmospheric pressure (e.g., during surgeries performed with patient in sitting position). [1] EtCO 2 is a semi-quantitative and non-invasive monitor of intermediate sensitivity for the detection of VAE. [2] However, decrement of EtCO 2 is not specific to VAE. Acute hypotension and pulmonary embolism due to any cause can also lead to a decrease in EtCO 2 . [3] We ruled out pulmonary embolism as to be the cause of the event as there were no predisposing factors associated in our patient. The other possibility was acute hypotension due to sudden blood loss, which may happen after rupture of venous sinuses during the initial part of the surgery. Acute hypotension can cause fall in EtCO 2 but unlike Use of dexmedetomidine for carotid artery stenting in a patient with multiple comorbidities body since 2 days. He was a smoker since last 50 years and was a known case of hypertension and Type 2 diabetes mellitus since last 10 year and chronic obstructive pulmonary disease (COPD) since last 3 years. He had a history of snoring and dyspnoea on exertion New York Heart Association grade 2 and had undergone coronary artery bypass grafting 15-years ago. He also had a history of hoarseness of voice 4 years ago for which he underwent laryngeal biopsy followed by microlaryngeal surgery (MLS) of a vocal cord nodule. The patient had complaints of mild hoarseness of voice following the laryngeal surgery. His routine haematological investigations were within normal limit. He had COPD changes in chest-X ray and his ECG showed ST depression in the in V3-V5, II and avF leads and right bundle branch block. He had a left ventricular ejection fraction (LVEF) of 50% with inferior wall regional wall motion abnormality (RWMA) and mild MR in 2D Echocardiography. He was edentulous, having a short neck and with a Mallampatti class (MPC) of 3. One respiratory system examination he had bilateral rhonchi and occasional crepititions in right lower lung area. He had grade 3 motor power in both left upper and lower extremity without any sensory deficit. Rest of the systemic examination was normal. As the patient was uncooperative pulmonary function test could not be performed. His medications included tab metformin (500 mg), glimeperide (1 mg), aspirin (75 mg), atrovastatin (20 mg), and tab losartan (50 mg) once a day and tab amlodipine (10 mg) twice a day. The patient was also receiving salbutamol and ipratropium inhalation three times a day and as when required. In the magnetic resonance angiography, he had >90% stenosis of right carotid artery and >50% stenosis of left carotid artery and he was scheduled for right carotid artery stenting (CAS). Since the patient refused for general anaesthesia and direct communication with the patient was desirable for the neuroradiologists, a decision to perform the procedure was scheduled to be performed under conscious sedation (CS).
The patient was advised to take all his scheduled medications (except metformin) before the procedure. We did not premedicate the patient. In the neuroradiological suite all the airway equipments and defibrillator was arranged and all routine monitors were attached. A left radial artery cannulation was performed under local anaesthesia and oxygen was administered through nasal prongs (at 4 l/min) along with continuous ETCO 2 monitoring. A bolus dose of Dexmedetomidine (1 µg/kg) was administered over 20 mins and the femoral artery puncture sites in both the limbs were infiltrated with 2% plain lignocaine solution. An infusion of dexmedetomidine was titrated to 0.1 µg/kg (dose that allowed a comfortable patient communicating with the neuroradiologists). Except two episodes of bradycardia and 1 episode of transient hypertension (all during stent placement) which were managed with glycopyrrolate and labetalol, respectively, the patient had stable vitals throughout the procedure. We discontinued the dexmedetomidine infusion approximately 15 mins before the end of the procedure. The patient had a smooth recovery and was shifted to the intensive care unit for observation.
The current recommendations for CAS are for patients with symptomatic severe stenosis (>70%) [1] and in patients with other coexisting medical abnormality. CAS is a safe therapeutic option. [2] Local anaesthesia, general anaesthesia or CS are available options for CAS. But profound sedation, airway obstruction and lack of patient cooperation are always a matter of concern during the use of sedative agents (propofol, midazolam, etc.) and use of benzodiazepine and/or opioid is associated with respiratory depression which is commonly seen in older patients and patients with COPD. [3] Dexmedetomidine is a selective alpha-2 adrenoreceptor agonist with sedative and analgesic effects. The other advantages of dexmedetomidine are lack of respiratory depression, better patient cooperation during sedation and easy arousal after sedation. [4, 5] The lack of respiratory depression and bronchodilatory effects of dexmedetomidine are useful properties which can be useful in patients with COPD. [3] Our patient had complaints of hoarseness of voice which might be due to some of laryngeal pathology which remained undiagnosed due to lack of follow-up after the MLS. So in the settings of COPD in an obese elderly patient with hoarseness of voice, a short neck and MPC of 3, the importance of lack of respiratory depression of dexmedetomidine cannot be over emphasised.
The reported cardiovascular effects of dexmedetomidine are bradycardia and hypotension which are usually temporary and can be treated with atropine or ephedrine and volume infusion. [3, 6] An initial hypertension followed by reflex decrease in heart rate has been described with dexmedetomidine administration and this response can be minimised by administering dexmedetomidine slowly over 10 mins. [7] In our case, we encountered two episodes of bradycardia at the time of carotid stent placement. As bradycardia and hypotension are reported complications of carotid stenting, [8] in our case, the episodes of bradycardia cannot be ascribed to dexmedetomidine infusion as the patient was receiving dexmedetomidine prior to that and there were no such events during that period. Current literature cautions against the use of dexmedetomidine in patients with compromised cardiac status, but our patient had marginally low LVEF. The use of dexmedetomidine has been reported to decrease the incidence of perioperative cardiac events and myocardial ischaemia [9] and animal study has shown decreased myocardial lactate release (direct measure of myocardial ischaemia) due to sympatholytic effect of dexmedetomidine. [10] So we used dexmedetomidine in our patient.
With this case report we want to emphasise upon the fact that dexmedetomidine has various advantages and which can be very useful while managing a patient with various systemic comorbidities.
hoarseness of voice, difficulty in breathing and dysphagia to solid foods. On examination, a mobile painless mass was found in the left-side of neck near the angle of jaw [ Figure 1a ]. Intra-oral examination revealed a large pharyngeal mass displacing the uvula to right side [ Figure 1b ]. All the routine investigations were within normal limit. Urinary vanillyl mandelic acid level was within normal range. The vital parameters were also normal. A diagnosis of large carotid body tumour was made after a plethora of investigations involving computed tomographic scan and magnetic resonance imaging and intra-arterial digital subtraction angiography of head and neck region [ Figure 2 ]. The patient was planned for embolisation of the carotid body tumour, under general anaesthesia, to reduce vascularity and tumour-size. He was pre-medicated with intramuscular glycopyrrolate 0.2 mg, 30 min before induction of anaesthesia. In view of anticipated difficult intubation, a 'difficult intubation cart' was kept ready. In the neuroradiology suite, anaesthesia was induced with intravenous propofol 100 mg and fentanyl 100 µg. Rocuronium 60 mg was given to facilitate endotracheal intubation without any difficulty. The monitoring modalities included electrocardiography, SPO 2 , end-tidal carbon dioxide (EtCO 2 ) and arterial BP.
